Given LDHB’s emerging role in cancer metabolism, particularly in tissues with high oxidative demands or in tumors that switch from LDHA to LDHB expression, selective LDHB inhibition may provide unique therapeutic advantages. The gene discussed is LDHB; the disease is cancer.